Passage Bio Inc. (PASG)
undefined
undefined%
At close: undefined
0.76
2.71%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue - - - - - -
Cost of Revenue 3.72M 3.68M 1.54M 800.00K 134.00K -
Gross Profit -3.72M -3.68M -1.54M -800.00K -134.00K -
Operating Income -108.39M -138.39M -185.73M -112.90M -37.19M -13.47M
Interest Income 5.60M 2.27M 343.00K 670.00K 696.00K -
Pretax Income -102.06M -136.13M -185.39M -112.23M -45.63M -12.77M
Net Income -102.06M -136.86M -191.50M -111.76M -54.58M -12.77M
Selling & General & Admin 41.58M 49.34M 60.06M 30.11M 6.95M 928.00K
Research & Development 61.42M 86.05M 117.67M 81.79M 29.74M 9.17M
Other Expenses 5.39M - - - - -
Operating Expenses 108.39M 135.39M 177.73M 111.90M 36.69M 10.10M
Interest Expense - 2.27M - - - -
Selling & Marketing Expenses - - - - - -
Cost & Expenses 108.39M 135.39M 177.73M 111.90M 36.69M 10.10M
Income Tax - 731.00K 6.11M -470.00K 8.95M -696.00K
Shares Outstanding (Basic) 54.74M 54.43M 53.34M 38.62M 45.80M 23.96M
Shares Outstanding (Diluted) 54.74M 54.43M 53.34M 38.62M 45.80M 23.96M
EPS (Basic) -1.86 -2.51 -3.59 -2.89 -1.19 -0.53
EPS (Diluted) -1.86 -2.51 -3.59 -2.89 -1.19 -0.53
EBITDA -98.34M -138.39M -185.73M -112.90M -36.55M -12.77M
Depreciation & Amortization 3.72M 3.68M 1.54M 800.00K 134.00K 10.10M